Jennifer Taubert to Retire as Executive Vice President and Worldwide Chairman, Innovative Medicine at Johnson & Johnson

Johnson & Johnson announced Jennifer Taubert will retire as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee, effective September 1, 2026.Original SEC Filing: JOHNSON & JOHNSON [ JNJ ] - 8-K - Aug. 04, 2026This is an AI-powered summary. It may…

Johnson & Johnson announced Jennifer Taubert will retire as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee, effective September 1, 2026.

IndividualJennifer Taubert

RoleExecutive Vice President, Worldwide Chairman, Innovative Medicine; member of the Executive Committee

Type of ChangeRetirement

Effective DateSeptember 1, 2026

ReasonRetirement

Replacement InfoNot disclosed

Background DetailsNot disclosed

Board/Committee Role ChangesNot disclosed

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.